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to determine the effects of diacerein on Il-1b stimulated chondrocytes
under hypoxia conditions.
Methods: Articular chondrocytes were obtained from human os-
teoarthritic knees after enzymatic digestion. Cells were maintained un-
der hypoxia conditions (5% O2, 5% CO2) and stimulated with Il-1Beta
for 24 h with or without diacerein. NO production was analyzed using
the Griess reagent to measure Nitrite in culture medium. iNOS and
COX-2 expression was analyzed by confocal microscopy (Leica) after
cell immunestaining. Moreover, proliferation and apoptosis of cells in all
conditions were also investigated. Human knee cartilage explants were
also used in this study. Explants were treated for 24 h with Il-1Beta with
or without diacerein to analyze GAG release into the culture medium.
Results: Human articular chondrocytes cultured under low oxygen ten-
sion respond to Il-1beta by an increase on NO production, reﬂected by
nitrite increase in culture medium. In parallel, an increase on iNOS ex-
pression was also observed after stimulation with the cytokine. Moreover,
the percentage of apoptotic cells after Il-1Beta treatment was higher
than in control where few apoptotic cells were found. When cartilage
explants were treated with Il-1Beta, we observed an increase on GAG
release in culture medium, reﬂecting extracellular matrix degradation.
When diacerein was added to culture medium containing Il-1Beta, NO
production, iNOS expression and apoptosis was markedly inhibited.
Moreover, diacerein reduced GAG release from human cartilage explants
treated with Il-1b, reﬂecting an inhibition on matrix degradation. However,
no effect of diacerein on COX-2 expression was observed under our
experiments conditions. Furthermore, proliferation was no affected in all
conditions used.
Conclusions: Our results show that diacerein could reduce the pro-
catabolic effects of Il-1Beta on osteoarthritic chondrocytes cultured in
conditions mimicking their hypoxic in vivo environment. The results
could partly explain the anti-osteoarthritic properties of Diacerein and
its disease-modifying effects on OA cartilage.
198 MORPHOFUNCTIONAL CHANGES OF CHONDROCYTES
DURING OSTEOARTHRITIS ARE RELATED WITH THE
EXPRESSION OF MOLECULES INVOLVED IN THE
INFLAMMATORY PROCESS
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Purpose: The aim of this study was to evaluate the molecular elements
involved in the phenotypic changes observed during osteoarthritis (OA)
progression in humans and rats.
Methods: The experimentally OA-induced model was accomplished by
unilateral knee menisectomy and post-surgery training; normal rats were
used as a control. Animals were sacriﬁced by CO2 overdose and right
femoral condyle was removed and processed for either electron mi-
croscopy (EM) or immunoﬂuorescence (IF). Cartilage samples from rats
with 1 to 5 training days (td) were used to evaluate ultrastructural changes
by EM. Moreover, cartilage from animals with 3, 6 and 10 td were analyzed
by IF for Fas, IFN-g, Il-1b, Il-6, Il-10, MMP3, MMP13, TGF-b1 TLR2, TLR4
and TNF-a. Programmed cell death was detected with TUNEL and IF for
caspase 3 and LC3II, in cartilage from rats with 20 and 45 td. At the
same time, development of ER and Golgi membranes was monitored
with the markers calnexin and 58k-9 respectively. Finally, cryosections
from human cartilage were stained with the raft marker cholera toxin B
subunit. Fluorescent signals were analyzed by confocal microscopy.
Results: Electron microscopy revealed changes in the superﬁcial zone
chondrocytes, where the cell phenotype changed from elongated to a
rounded shape. During the ﬁrst 5 td, chondrocytes developed prominent
ER with dilated cisterns and enhanced Golgi membranes. Expression
of the proinﬂammatory cytokines IL1-b, TNF-a and Il-6 began at 6 td,
in the superﬁcial zone and reached their highest levels at 10 td in all
the cartilage zones. TGF-b1 showed a similar proﬁle. In contrast, IFN-g
showed high levels at 6 td that decreased at 10 td. Expression of Il-10
remained without changes during the time-course of the experiment.
MMP-3, MMP-13, TLR2 and TLR4 raised their levels in a time dependent
manner in all cartilage zones. Cell death analysis, revealed expression of
molecules involved in both autophagy (LC3II) and apoptosis (TUNEL and
caspase 3) at 20 and 45 td. Expression of 58k-9 and calnexin in cartilage
from rats with 20 and 45 td were increased. Finally, in situ lipid rafts (LR)
were increased in OA cartilage compared with normal donors, in both
superﬁcial and medial zone chondrocytes.
Conclusions: Our results suggest that during OA progression chon-
drocytes undergo dramatic phenotypic changes and display signaling
transduction machinery capable of inducing its own morpho-functional
changes. In early OA, chondrocytes increase ER and Golgi in order
to synthesize proteins required for reparation of ECM. However, when
the repair capacity is overwhelmed, chondrocytes begin the synthesis of
catabolic molecules like Il-1b, Il-6, TNF-a, MMP3 and MMP-13 that stim-
ulate an inﬂammatory process and degradation of ECM. The expression
of catabolic proteins could be regulated via Fas or TLR activation. The
signaling activation could take place in LR, since, our results provides
evidence that in situ clustered LR are enhanced in OA cartilage. Fur-
thermore, the decrease of anti-inﬂammatory molecules in OA could be
involved in the beginning of the disease. Finally, when chondrocytes lost
their reparative capacity, execute its own cell death program that include
both autophagy and apoptosis.
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Purpose: To investigate the response of proteoglican to different muscle
stretching protocols.
Methods: Thirty male albino rats were divided into six groups: I im-
mobilized; IS7 immobilized and stretched seven days/week; IS3 immo-
bilized and stretched three days/week; S7 stretched seven days/week;
S3 stretched three days/week and C control. These groups were used in
this experiment. The I, IS3 and IS7 groups were immobilized for 4 weeks.
In the muscle stretching protocol, the treated ankle joint (groups IS3,
IS7, S3 and S7) was manually full dorsal ﬂexed 10 times for 60 s with
a 30 s interval between each 60 s period, 7 or 3 days a week for
3 weeks, to stretch the ankle plantar ﬂexor muscle group. The right
hind limb was free to move. At the end of the experiment, the ankles
were removed, processed in parafﬁn and stained with Safranin-O to
evaluate the proteoglican response. Two blinded observers evaluated the
Safranin-O staining, from treated and non-treated hind limbs using a light
microscope. To compare loss of safranin-o staining graduation among
groups it was used Kruscal Wallis and post hoc Newman Keuls statiscal
analysis.
Results: All the groups, except the group stretched for 7 days a week
presented proteoglican loss in the non-treated limbs compared to the
controls. The higher loss in the non-treated limbs was found in the
animals from groups immobilized and stretched for 3 and 7 days a week.
Concerning the treated hind limbs, all groups, except the group stretched
for 7 days a week presented proteoglican loss compared to the controls.
As well as the non treated limbs, the higher proteoglican loss was in the
immobilized and stretched for 3 and 7 days a week group.
Conclusions: According to the results of the present study, the articu-
lar cartilage is susceptible to proteoglican loss having different stimuli.
However, immobilization, different frequencies of stretching, overload in
the contralateral limb and immobilization followed by muscle stretching
caused different degrees of loss. The present muscle stretching protocol
applied after immobilization seems to be a trigger of harm to both limbs,
treated and contralateral when applied daily or on alternate days.
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Purpose: Osteoarthritis (OA) is the most common rheumatologic disease
involving cartilage alterations in both proteoglycans and the collagen
network. One of the proteoglycan families is the small leucine rich
proteoglycans (SLRPs). SLRPs are characterized by their association
with collagen ﬁbrils. Opticin is a glycoprotein and class III member of
the SLRP family, which was initially identiﬁed to be associated with the
collagen ﬁbrils of the vitreous humor of the eye. Recently, we showed
that opticin is present in human articular tissues, and that MMP-13,
the key metalloprotease involved in cartilage pathology, cleaves human
cartilage opticin. Here, we examined the ability of other human MMPs
and ADAMTS involved in OA pathology to cleave opticin and investigated
their patterns of degradation.
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Methods: Opticin was extracted from normal and OA human cartilage
using guanidinium chloride (4M) extraction and examined by Western
blotting. Human MMP 1, -2, -3, -7, -8, -9 and ADAMTS-4, -5 proteolytic
activities on opticin were analyzed on normal and OA cartilage extracts
incubated for 0−24 hours
Results: One of the emerging observations was that all MMPs and
ADAMTS tested, except MMP-9, cleaved opticin in both normal and OA
specimens. Interestingly, MMP-7 and -8 were the most effective, and
degradation occurred as early as 15 minutes of incubation. At which
time, degradation was almost complete for MMP-7, suggesting that this
molecule is a preferential substrate for this enzyme. In contrast, MMP-1
was the least effective and degradation was noted after an incubation
of 16 hours. The others enzymes showed degradation starting at about
2 hours. The degradation pattern, except for MMP-7 in which degradation
appeared independent of the specimen types, was different between
normal and OA. In general, the degradation pattern was slower in normal
than in OA specimens, reﬂecting an increased sensitivity of opticin to
degradation when the cartilage was damaged. Fragments were also
detected, but the number and size differed depending on the protease.
This indicates different digestion sites among the proteases. Surprisingly,
MMP-1 and -2 generated different opticin degradation fragments when
normal were compared to OA specimens. The different opticin protease
cleavage sites are currently under study.
Conclusions: We showed, for the ﬁrst time, the ability of different MMP
and ADAMTS to degrade opticin. As opticin may contribute to the struc-
tural stability of cartilage matrix, its cleavage may predispose cartilage to
degradation. In vivo identiﬁcation of the cleavage products may assist in
an early detection of OA cartilage matrix degeneration.
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PROTEIN IN OSTEOARTHRITIC CHONDROCYTES IN
RESPONSE TO HIGH EXTRACELLULAR GLUCOSE
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Purpose: Diabetes mellitus is an important risk factor for osteoarthritis
(OA), but the mechanisms involved are largely unknown. In chondrocytes,
glucose is essential for energy production and the synthesis of matrix
components. Diabetic patients can experience extended episodes of
hyper- and hypoglycemia that are likely to affect the delivery of glucose
to the synovial joint and its availability to chondrocytes. Glucose transport
is the limiting step in glucose utilization and the facilitative glucose
transporter-1 (GLUT-1) is the major glucose transporter in chondrocytes.
This study aimed at comparing the ability of normal and OA chondrocytes
to regulate glucose uptake and GLUT-1 levels in response to high and
low extracellular glucose concentrations.
Methods: Normal human chondrocytes were isolated from the femoral
condyles of multi-organ donors. OA chondrocytes were isolated from
the cartilage obtained from patients undergoing total knee replacement
surgery. Serum-starved subconﬂuent chondrocyte cultures were incu-
bated in media with 0, 10 or 30mM glucose. Total GLUT-1 content
was evaluated by western blotting. Glucose transport was determined
by measuring the uptake of non-metabolizable 2-Deoxy-D-2-[2,6-3H] glu-
cose into chondrocytes for 30 minutes at 37ºC. GLUT-1 gene expression
was measured by Real Time PCR. To determine the role of lysosomes in
GLUT-1 regulation, chondrocyte cultures in regular (10mM glucose) or
high glucose (30mM) medium were treated with 20 mM chloroquine, an
inhibitor of lysosome function, for the last 6 hours of an 18 hour incubation
period.
Results: Treatment of normal chondrocytes with 30mM glucose for
either 18 or 48 hours signiﬁcantly decreased 2-Deoxy-D-Glucose uptake
(75.4±3.6% and 71.5±2.6%, respectively) and GLUT-1 protein levels
(68.2±9.1% and 64.6±6.0%, respectively) relative to cells cultured under
10mM glucose. In contrast, 2-Deoxy-D-Glucose uptake (102.5±3.1%)
and GLUT-1 levels (116.51±9.6%) remained unchanged in OA chon-
drocytes cultured for 48 hours in the high glucose medium. GLUT-1
mRNA levels, either in normal or OA chondrocytes, were not affected by
treatment with high glucose for 6, 12 or 24 h. Similarly to normal cells, OA
chondrocytes responded to glucose deprivation by increasing 2-Deoxy-
D-Glucose uptake (128±2%) and total GLUT-1 levels (137.8±8.6%).
Treatment with 20mM chloroquine signiﬁcantly increased total GLUT-1
protein in normal chondrocytes, both under regular (10mM) and high
glucose conditions.
Conclusions: OA chondrocytes are capable of upregulating the net rate
of glucose transport and GLUT-1 protein when deprived of glucose,
suggesting that they are capable of sensing and adjusting to low extracel-
lular glucose concentrations. However, unlike normal chondrocytes, OA
chondrocytes fail to downregulate glucose transport and GLUT-1 protein
under high glucose concentrations. This may lead to an abnormally high
intracellular glucose concentration, which in turn may lead to altered cell
function and the formation of glycation end products during extended
periods of hyperglycemia in vivo. The lack of signiﬁcant differences in
GLUT-1 mRNA, together with GLUT-1 accumulation in normal chon-
drocytes exposed to chloroquine, indicate that GLUT-1 downregulation
depends on lysosomal degradation. The role of lysosomal function in
the inability of OA chondrocytes to adequately respond to high glucose
remains to be elucidated.
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Purpose: Previously we have shown that cartilage chondrocyte alkaline
phosphatase (ALP) is up regulated in active osteoarthritis (OA) and down
regulated in calcium pyrophosphate dihydrate (CPPD) crystal deposition
disease. Furthermore, CPPD crystals can be dissolved by the action
of ALP provided that the enzyme is bound to the crystals. Modulating
the action of ALP would then suggest a possible route to affect these
conditions. To obtain a better understanding of the action of ALP on
CPPD crystal dissolution, we investigated inhibition by endogenous amino
acids on ALP substrates; organic phosphate, inorganic pyrophosphate,
and CPPD crystals.
Methods: CPPD crystals were made using established methods de-
veloped in our laboratory. The phosphatase (Piase), pyrophosphate
hydrolase (PPiase), and CPPD crystal dissolution activities of tissue
nonspeciﬁc alkaline phosphatase (TNAP) were investigated in vitro using
cysteine and mercaptopyruvate (MPA) as inhibitors of Bovine kidney
ALP. Enzyme activity was determined by measuring liberated inorganic
phosphate (Pi) from p-Nitrophenyl phosphate (pNPP), or Sodium py-
rophosphate, at speciﬁc times and conditions. CPPD crystal dissolution
was assessed by measuring [Pi] liberated into solution in the presence of
TNAP. To assess enzyme inhibition, kinetics parameters such as Vmax
and Km, were determined and speciﬁc activities were calculated from Ini-
tial Velocity, Eadie-Hofstee, Simple, Dixon, and Secondary plots. Assays
were run under physiologic conditions with Tris-HCl buffer, pH=7.4 and at
37ºC. TNAP was at 200U/L and the buffer was supplemented with 1mM
Ca++ and 1mM Mg++. Enzyme activity was expressed as nmoles Pi/unit
TNAP/minute.
Results: At physiologic concentration, cysteine had no inhibitory effect
on any activity of TNAP. At 10× physiologic concentration, cysteine
signiﬁcantly inhibited phosphatase and pyrophosphate hydrolase activity
but did not inhibit CPPD crystal dissolution. MPA and cysteine together
inhibited TNAP’s phosphatase and pyrophosphate hydrolase activity at
physiologic concentration while CPPD crystal dissolution was only slightly
inhibited. When the two inhibitors were increased to 10x physiologic
concentration, all enzyme activity decreased signiﬁcantly as is shown
in the summary table.
Effect of Amino Acid Inhibitors on Enzyme Activity
Enzyme Substrate Inhibitors
Concentration nmolesPi/unit ALP/Minute
× physiological Cysteine Cysteine + MPA
% %
ALP (Piase) pNPP 2000uM 0 29 100 28 100
1× 28 98 8 29
10× 11 37 4 14
ALP (PPiase) Pyrophosphate 2000 uM 0 27 100 55 100
1× 30 110 21 39
10× 18 66 19 34
ALP CPPD 50ug/mL 0 0.46 100 0.26 100
1× 0.49 107 0.23 88
10× 0.43 93 0.10 38
Conclusions: The amino acids cysteine and MPA together are capable of
inhibiting phosphatase and pyrophosphate hydrolase activity of TNAP at
